cs.CVNov 11, 2026

PCLSegNet: Anatomy-Aware Deep Learning Framework for MRI-based Pancreatic Cyst Segmentation and Size Assessment

Authors: Hanyi Zhang, Tongyu Wang, Manuel Debic, Markus Wennmann, Johannes Haubold, Tamara Schikowski, Wilfried Reichardt, Fabian Bamberg, 

Organizations: Clinic for Diagnostic and Interventional Radiology, Heidelberg University Hospital, Medical Faculty of Heidelberg University, Heidelberg, Germany · Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany · Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China · Division for Computational Radiology and Clinical AI, University Hospital Bonn, Faculty of Medicine at the University of Bonn, Bonn, Germany · 

Abstract

Early detection and follow-up of pancreatic cystic lesions (PCLs) are crucial, as some of their subtypes, such as mucinous cystic neoplasms (MCNs) and intraductal papillary mucinous neoplasms, carry a significant risk of malignant transformation. Although most AI studies investigating PCLs rely on computed tomography (CT) scans, magnetic resonance imaging (MRI) offers superior soft tissue contrast, making it highly suitable for PCLs assessment. In this work, we propose an anatomy-aware two-stage deep learning framework for automated PCLs segmentation on abdominal MRI scans. First, a publicly available pancreas segmentation model is used to localize the pancreas. Then, we introduce the anatomyaware PCLSegNet, which incorporates anatomical priors as guidance for pancreas and PCLs segmentation. To address the class imbalance problem, we develop a Class-Specific ErrorWeighted (CSEW) loss function. Postprocessing is applied through anatomical constraints.Our proposed method outperforms multi-organ segmentation models such as TotalSegmentator, achieving substantially higher Dice scores for pancreas segmentation. Moreover, it also achieves a superior normalized surface Dice (NSD) and recall for PCLs segmentationcompared to other state-of-the-art models like nnU-Net, while also notably reducing the false negative rate, facilitating the automatic early detection and the noninvasive imaging-based assessment of PCLs.

Figures & tables

Appendix figures & tables1 asset

Supplementary material from the paper’s appendix.

Appendix

Explore similar work

Oct 29, 2026

Segment Anything Pancreas: A Unified MRI Segmentation Model for Pancreatic Cancer Radiotherapy

Background: Limited tumor annotations and incomplete labels across MRI datasets hinder unified segmentation of pancreatic tumors and organs at risk (OARs) for MRI-guided radiotherapy. Purpose: We propose Pancreas-MedNeXt, a unified model that segments the whole pancreas, its subregions, tumors, and surrounding OARs from one MRI volume. Methods: The model uses a shared MedNeXt encoder-decoder with supervised whole-pancreas and subregion pretraining, followed by multitask fine-tuning. Three output heads predict the pancreatic subregions, tumor, and OARs (stomach, duodenum, kidneys). An annotation-aware loss allows training on partially labeled data without treating unannotated structures as background. Pancreas and tumor were evaluated by three-fold cross-validation on 142 PANTHER patients (92 diagnostic, 50 MR-Linac), subregions and OARs on Cyst-X and AMOS test sets, and pancreas and OARs on 33 external T1-weighted TotalSegmentator scans. Comparisons with nnU-Net, MedNeXt, VISTA3D, and Swin UNETR used the Dice similarity coefficient (DSC) with paired bootstrap 95% CIs. Results: Pancreas-MedNeXt achieved the highest mean pancreas and tumor DSC on diagnostic and MR-Linac MRI. Tumor DSC was 58.41% and 42.55%, exceeding task-specific MedNeXt by 4.94 (95% CI: 0.28-9.45) and 5.89 (95% CI: 2.37-9.72) percentage points, respectively. Whole-pancreas DSC was 85.73% and 70.66%. Pretraining improved head, body, and tail DSC by 2.01, 3.00, and 3.78 percentage points over training from scratch. It also achieved the highest DSC for the pancreas, duodenum, and right kidney on AMOS, and for all five organs on external MRI, exceeding the next-best method by 4.92-8.85 percentage points.Conclusion: A single Pancreas-MedNeXt model segments tumors, pancreatic subregions, and OARs on diagnostic and MR-Linac MRI, which could streamline contouring for pancreatic cancer radiotherapy.
Apr 20, 2026

CrossPan: A Comprehensive Benchmark for Cross-Sequence Pancreas MRI Segmentation and Generalization

Automatic pancreas segmentation is fundamental to abdominal MRI analysis, yet deep learning models trained on one MRI sequence often fail catastrophically when applied to another-a challenge that has received little systematic investigation. We introduce CrossPan, a multi-institutional benchmark comprising 1,386 3D scans across three routinely acquired sequences (T1-weighted, T2-weighted, and Out-of-Phase) from eight centers. Our experiments reveal three key findings. First, cross-sequence domain shifts are far more severe than cross-center variability: models achieving Dice scores above 0.85 in-domain collapse to near-zero (<0.02) when transferred across sequences. Second, state-of-the-art domain generalization methods provide negligible benefit under these physics-driven contrast inversions, whereas foundation models like MedSAM2 maintain moderate zero-shot performance through contrast-invariant shape priors. Third, semi-supervised learning offers gains only under stable intensity distributions and becomes unstable on sequences with high intra-organ variability. These results establish cross-sequence generalization-not model architecture or center diversity-as the primary barrier to clinically deployable pancreas MRI segmentation. Dataset and code are available at https://crosspan.netlify.app/.
Jul 29, 2025

Cyst-X: A Multicenter MRI Benchmark for Pancreatic Cyst Risk Stratification and Cross-Institutional AI

Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic cancer precursors, and guideline-based risk stratification both over-treats indolent lesions and misses progression. We present Cyst-X, a public benchmark of 1,461 T1-weighted (T1W) and T2-weighted (T2W) MRI volumes from 764 patients at seven centers, with expert pancreas masks, risk labels, splits and reference AI risk-prediction models. PanSegNet segmented the pancreas with Dice of 86.34% (T1W) and 89.26% (T2W) on held-out centers. For the primary task, high-risk versus low-risk IPMN, a 3D DenseNet-121 achieved cross-validated AUCs of 74.59% and 73.45%; complementary broad binary and three-class tasks reached 78.67--81.28% and 73.47--75.76%. Because patient images often cannot be pooled across institutions, we also simulated federated learning across the seven centers. On T2W MRI, FedProx was similar to centralized training in center-averaged external AUC (71.00% versus 71.18%) but not in pooled AUC (62.35% versus 77.49%). Radiologist comparisons showed cohort-dependent sensitivity--specificity tradeoffs. Cyst-X supports reproducible method development and identifies within-IPMN risk discrimination and cross-center score comparability as open challenges.